PDF herunterladen
Planta Med 2013; 79(12): 1084-1095
DOI: 10.1055/s-0033-1350620
Biological Screening
Original Papers
Georg Thieme Verlag KG Stuttgart · New York

Screening of Medicinal Plants for PPARα and PPARγ Activation and Evaluation of Their Effects on Glucose Uptake and 3T3-L1 Adipogenesis

Min Hye Yang
1   National Center for Natural Products Research, Research Institute of Pharmaceutical Sciences, School of Pharmacy, University of Mississippi, MS, USA
,
Bharathi Avula
1   National Center for Natural Products Research, Research Institute of Pharmaceutical Sciences, School of Pharmacy, University of Mississippi, MS, USA
,
Troy Smillie
1   National Center for Natural Products Research, Research Institute of Pharmaceutical Sciences, School of Pharmacy, University of Mississippi, MS, USA
,
Ikhlas A. Khan
1   National Center for Natural Products Research, Research Institute of Pharmaceutical Sciences, School of Pharmacy, University of Mississippi, MS, USA
2   Department of Pharmacognosy, School of Pharmacy, University of Mississippi, MS, USA
,
Shabana I. Khan
1   National Center for Natural Products Research, Research Institute of Pharmaceutical Sciences, School of Pharmacy, University of Mississippi, MS, USA
2   Department of Pharmacognosy, School of Pharmacy, University of Mississippi, MS, USA
› Institutsangaben
Weitere Informationen

Publikationsverlauf

received 25. Februar 2013
revised 17. Mai 2013

accepted 20. Juni 2013

Publikationsdatum:
22. Juli 2013 (online)

Auch verfügbar auf
    Lizenzen und Reprints

Abstract

Medicinal plants are a rich source of ligands for nuclear receptors. The present study was aimed to screen a collection of plant extracts for PPARα/γ-activating properties and identify the active extract that can stimulate cellular glucose uptake without enhancing the adipogenesis. A reporter gene assay was performed to screen ethanolic extracts of 263 plant species, belonging to 94 families, for activation of PPARα and PPARγ. Eight extracts showed activation of PPARγ, while 22 extracts showed activation of PPARα. The extracts of five plants (Daphne gnidium, Illicium anisatum, Juniperus virginiana, Terminalia chebula, and Thymelaea hirsuta) showed activation of both PPARα and PPARγ and out of them, D. gnidium and T. hirsuta markedly increased PPARα/γ protein expression. All five extracts showed an increase in cellular glucose uptake. Of the five dual agonists, T. chebula and T. hirsuta did not show any increase in differentiation of 3T3-L1 preadipocytes, but I. anisatum caused an increase in adipogenesis, while D. gnidium and J. virginiana were toxic to adipocytes. The adipogenic effect of rosiglitazone was antagonized by T. chebula and T. hirsuta. It was concluded that T. hirsuta and T. chebula retain the property of elevating glucose uptake as PPARα/γ dual agonists without the undesired side effect of adipogenesis. This is the first report to reveal the PPARα/γ dual agonistic action and glucose uptake enhancing property of T. hirsuta and T. chebula.

Key words

type 2 diabetes - PPARα and PPARγ activation - glucose uptake stimulation - adipocyte differentiation - Thymelaea hirsuta - Thymelaeaceae - Terminalia chebula - Combretaceae
 

  • References

  • 1 Sacks DB, McDonald JM. The pathogenesis of type II diabetes mellitus. A polygenic disease. Am J Clin Pathol 1996; 105: 149-156
    PubMedGoogle Scholar
  • 2 Dagogo-Jack S, Santiago JV. The natural history of type 2 diabetes. A Special Report: Managing Type 2 Diabetes. New Science and New Strategies. Post Graduate Medicine. New York: McGraw-Hill Companies, Inc.; 1998
    CrossrefGoogle Scholar
  • 3 DeFronzo RA. The triumvirate: β-cell, muscle, liver. A collusion responsible for NIDDM. Diabetes 1988; 37: 667-687
    CrossrefPubMedGoogle Scholar
  • 4 Reaven GM. Role of insulin resistance in human disease. Diabetes 1988; 37: 1595-1607
    CrossrefPubMedGoogle Scholar
  • 5 Attele AS, Zhou YP, Xie JT, Wu JA, Zhang L, Dey L, Pugh W, Rue PA, Polonsky KS, Yuan CS. Antidiabetic effects of Panax ginseng berry extract and the identification of an effective component. Diabetes 2002; 51: 1851-1858
    CrossrefPubMedGoogle Scholar
  • 6 Yki-Yarvinen H. Toxicity of hyperglycaemia in type 2 diabetes. Diabet Metab Rev 1998; 14: S45-S50
    CrossrefPubMedGoogle Scholar
  • 7 Zimmet PZ. Diabetes epidemiology as a tool to trigger diabetes research and care. Diabetologia 1999; 42: 499-518
    CrossrefPubMedGoogle Scholar
  • 8 Berger JP, Akiyama TE, Meinke PT. PPARs: therapeutic targets for metabolic disease. Trends Pharmacol Sci 2005; 26: 244-251
    CrossrefPubMedGoogle Scholar
  • 9 Desvergne B, Wahli W. Peroxisome proliferator-activated receptors: nuclear control of metabolism. Endocrinol Rev 1999; 20: 649-688
    CrossrefPubMedGoogle Scholar
  • 10 Chawla A, Schwarz EJ, Dimaculangan DD, Lazar MA. Peroxisome proliferator-activated receptor (PPAR) γ: adipose-predominant expression and induction early in adipocyte differentiation. Endocrinology 1994; 135: 798-800
    CrossrefPubMedGoogle Scholar
  • 11 Willson TM, Cobb JE, Cowan DJ, Wiethe RW, Correa ID, Prakash SR, Beck KD, Moore LB, Kliewer SA, Lehmann JM. The structure activity relationship between peroxisome proliferator activated receptor γ agonism and the antihyperglycemic activity of thiazolidinediones. J Med Chem 1996; 39: 665-668
    CrossrefPubMedGoogle Scholar
  • 12 Turmelle YP, Shikapwashya O, Tu S, Hruz PW, Yan Q, Rudnik DA. Rosiglitazone inhibits mouse liver regeneration. FASEB J 2006; 20: 2609-2611
    CrossrefPubMedGoogle Scholar
  • 13 de Souza CJ, Eckhardt M, Gagen K, Dong M, Chen W, Laurent D, Burkey BF. Effects of pioglitazone on adipose tissue remodeling within the setting of obesity and insulin resistance. Diabetes 2001; 50: 1863-1871
    CrossrefPubMedGoogle Scholar
  • 14 Alarcon-Aguilara FJ, Roman-Ramos R, Perez-Gutierrez S, Aguilar-Contreras A, Contreras-Weber CC, Flores-Saenz JL. Study of the anti-hyperglycemic effect of plants used as antidiabetics. J Ethnopharmacol 1998; 61: 101-110
    CrossrefPubMedGoogle Scholar
  • 15 Yun JW. Possible anti-obesity therapeutics from nature – A review. Phytochemistry 2010; 71: 1625-1641
    CrossrefPubMedGoogle Scholar
  • 16 Prabhakar PK, Doble M. A target based therapeutic approach towards diabetes mellitus using medicinal plants. Curr Diabet Rev 2008; 4: 291-308
    PubMedGoogle Scholar
  • 17 Liu Q, Chen L, Hu L, Guo Y, Shen X. Small molecules from natural sources, targeting signaling pathways in diabetes. Biochem Biophys Acta 2010; 1799: 854-865
    PubMedGoogle Scholar
  • 18 Huang THW, Teoh AW, Lin BL, Lin DSH, Roufogalis B. The role of herbal PPAR modulators in the treatment of cardiometabolic syndrome. Pharmacol Res 2009; 60: 195-206
    CrossrefPubMedGoogle Scholar
  • 19 Huang TH, Kota BP, Razmovski V, Roufogalis BD. Herbal or natural medicines as modulators of peroxisome proliferator-activated receptors and related nuclear receptors for therapy of metabolic syndrome. Basic Clin Pharmacol Toxicol 2005; 96: 13-14
    CrossrefPubMedGoogle Scholar
  • 20 Rau O, Wurglics M, Dingermann T, Abdel-Tawab M, Schubert-Zsilavecz M. Screening of herbal extracts for activation of the human peroxisome proliferators-activated receptor. Pharmazie 2006; 61: 952-956
    PubMedGoogle Scholar
  • 21 Laville M, Andreelli F. Mechanisms for weight gain during blood glucose normalization. Diabet Metab 2000; 26: 42-45
    PubMedGoogle Scholar
  • 22 Peters JM, Hennuyer N, Staels B, Fruchart JC, Fievet C, Gonzalez FJ, Auwerx J. Alterations in lipoprotein metabolism in peroxisome proliferator-activated receptor α-deficient mice. J Biol Chem 1997; 272: 27307-27312
    CrossrefPubMedGoogle Scholar
  • 23 Rubins HB, Robins SJ, Collins D, Nelson DB, Elam MB, Schaefer EJ, Faas FH, Anderson JW. Diabetes, plasma insulin, and cardiovascular disease: subgroup analysis from the Department of Veterans Affairs high-density lipoprotein intervention trial (VA-HIT). Arch Intern Med 2002; 162: 2597-2604
    CrossrefPubMedGoogle Scholar
  • 24 Jarald E, Joshi SB, Jain DC. Diabetes and Herbal Medicines. Iran J Pharmacol Ther 2008; 7: 97-106
    PubMedGoogle Scholar
  • 25 Flevét C, Fruchart JC, Staels B. PPARα and PPARγ dual agonists for the treatment of type 2 diabetes and the metabolic syndrome. Curr Opin Pharmacol 2006; 6: 606-614
    CrossrefPubMedGoogle Scholar
  • 26 Xu J, Ma M, Purcell WM. Characterization of some cytotoxic endpoints using rat liver and HepG2 spheroids as in vitro models and their application in hepatotoxicity studies. I. Glucose metabolism and enzyme release as cytotoxic markers. Toxicol Appl Pharmacol 2003; 189: 100-111
    CrossrefPubMedGoogle Scholar
  • 27 El Amrani F, Rhallab A, Alaoui T, El Badaoui K. Hypoglycaemic effect of Thymelaea hirsuta in normal and streptozotocin-induced diabetic rats. J Med Plants Res 2009; 3: 625-629
    PubMedGoogle Scholar
  • 28 Verma N, Singh AP, Amresh G, Sahub PK, Singha A, Mishrab N. Review on wonderful and miraculous Triphala. J Pharm Res 2011; 4: 690-694
    PubMedGoogle Scholar
  • 29 Bnouham M, Mekhfi H, Legssyer AK, Ziyyat A. Medicinal plants used in the treatment of diabetes in Morocco. Int J Diabet Metab 2002; 10: 33-50
    PubMedGoogle Scholar
  • 30 Singh I, Singh PK, Bhansali S, Shafiq N, Malhotra S, Pandhi P, Singh AP. Effects of three different doses of a fruit extract of Terminalia chebula on metabolic components of metabolic syndrome, in a rat model. Phytother Res 2010; 24: 107-112
    CrossrefPubMedGoogle Scholar
  • 31 Ntambi JM, Kim YC. Adipocyte differentiation and gene expression. J Nutr 2000; 130: S3122-S3126
    PubMedGoogle Scholar
  • 32 Rosen ED. The transcriptional basis of adipocyte development. Prostaglandins Leukot Essent Fatty Acids 2005; 73: 31-34
    CrossrefPubMedGoogle Scholar
  • 33 Rosen ED, Sarraf P, Troy AE, Bradwin G, Moore K, Milstone DS, Spiegelman BM, Mortensen RM. PPARγ is required for the differentiation of adipose tissue in vivo and in vitro . Mol Cell 1999; 4: 611-617
    CrossrefPubMedGoogle Scholar
  • 34 Ristow M, Muller-Wieland D, Pfeiffer A, Krone W, Kahn CR. Obesity associated with a mutation in a genetic regulator of adipocyte differentiation. N Engl J Med 1998; 339: 953-959
    CrossrefPubMedGoogle Scholar
  • 35 Kumanyika S, Jeffery RW, Morabia A, Ritenbaugh C, Antipatis VJ. Obesity prevention: the case for action. Public Health Approaches to the Prevention of Obesity (PHAPO) Working Group of the International Obesity Task Force (IOTF). Int J Obes Relat Metab Disord 2002; 26: 425-436
    CrossrefPubMedGoogle Scholar
  • 36 Okuno A, Tamemoto H, Tobe K, Ueki K, Mori Y, Iwamoto K, Umesono K, Akanuma Y, Fujiwara T, Horikoshi H, Yazaki Y, Kadowaki T. Troglitazone increases the number of small adipocytes without the change of white adipose tissue mass in obese Zucker rats. J Clin Invest 1998; 101: 1354-1361
    CrossrefPubMedGoogle Scholar
  • 37 Weyer C, Foley JE, Bogardus C, Tataranni PA, Pratley RE. Enlarged subcutaneous abdominal adipocyte size, but not obesity itself, predicts type II diabetes independent of insulin resistance. Diabetologia 2000; 43: 1498-1506
    CrossrefPubMedGoogle Scholar
  • 38 Christensen KB, Minet A, Svenstrup H, Grevsen K, Zhang H, Schrader E, Rimbach G, Wein S, Wolffram S, Kristiansen K, Christensen LP. Identification of plant extracts with potential antidiabetic properties: effect on human peroxisome proliferator-activated receptor (PPAR), adipocyte differentiation and insulin-stimulated glucose uptake. Phytother Res 2009; 23: 1316-1325
    CrossrefPubMedGoogle Scholar
  • 39 Heim M, Johnson J, Boess F, Bendik I, Weber P, Hunziker W, Flühmann B. Phytanic acid, a natural peroxisome proliferator-activated receptor (PPAR) agonist, regulates glucose metabolism in rat primary hepatocytes. FASEB J 2002; 16: 718-720
    PubMedGoogle Scholar
  • 40 Avula B, Wang YH, Wang M, Shen YH, Khan IA. Simultaneous determination and characterization of tannins and triterpene saponins from the fruits of various species of Terminalia and Phyllantus emblica using a UHPLC-UV-MS method: application to triphala. Planta Med 2013; 79: 181-188
    Artikel in Thieme ConnectPubMedGoogle Scholar
  • 41 Pfundstein B, El DSK, Hull WE, Haubner R, Erben G, Owen RW. Polyphenolic compounds in the fruits of Egyptian medicinal plants (Terminalia bellerica, Terminalia chebula and Terminalia horrida): Characterization, quantitation and determination of antioxidant capacities. Phytochemistry 2010; 71: 1132-1148
    CrossrefPubMedGoogle Scholar
  • 42 Brooks G, Evans AT, Aitken A, Evans FJ, Rizk AFM, Hammouda FM, El-Missiry MM, Ismail SE. Daphnane diterpenes of Thymelaea hirsuta . Phytochemistry 1990; 29: 2235-2237
    CrossrefPubMedGoogle Scholar
  • 43 Miyamae Y, Villareal MO, Abdrabbah MB, Isoda H, Shigemori H. Hirseins A and B, daphnane diterpenoids from Thymelaea hirsuta that inhibit melanogenesis in B16 melanoma cells. J Nat Prod 2009; 72: 938-941
    CrossrefPubMedGoogle Scholar
  • 44 Trigui M, Hsouna AB, Tounsi S, Jaoua S. Chemical composition and evaluation of antioxidant and antimicrobial activities of Tunisian Thymelaea hirsuta with special reference to its mode of action. Indian Crop Prod 2013; 41: 150-157
    PubMedGoogle Scholar
  • 45 Rizk AM, Hammouda FM, Ismail SI. Phytochemical investigation of Thymelea hirsuta. II. Lipid fraction. Planta Med 1974; 26: 346-358
    Artikel in Thieme ConnectPubMedGoogle Scholar
  • 46 Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983; 65: 55-63
    CrossrefPubMedGoogle Scholar
  • 47 Mizuno CS, Ma G, Khan S, Patny A, Avery MA, Rimando AM. Design, synthesis, biological evaluation and docking studies of pterostilbene analogs inside PPARα . Bioorg Med Chem 2008; 16: 3800-3808
    CrossrefPubMedGoogle Scholar
  • 48 Jaradat MS, Wongsud B, Phornchirasilp S, Rangwala SM, Shams G, Sutton M, Romstedt KJ, Noonan DJ, Feller DR. Activation of peroxisome proliferator-activated receptor isoforms and inhibition of prostaglandin H2 synthases by ibuprofen, naproxen, and indomethacin. Biochem Pharmacol 2001; 62: 1587-1595
    CrossrefPubMedGoogle Scholar
  • 49 Chen QC, Zhang WY, Jin W, Lee IS, Min BS, Jung HJ, Na M, Lee S, Bae K. Flavonoids and isoflavonoids from Sophorae flos improve glucose uptake in vitro . Planta Med 2010; 76: 79-81
    Artikel in Thieme ConnectPubMedGoogle Scholar
  • 50 Wang L, Xu ML, Rasmussen SK, Wang MH. Vomifoliol 9-O-α-arabinofuranosyl (1 → 6)-β-D-glucopyranoside from the leaves of Diospyros kaki stimulates the glucose uptake in HepG2 and 3 T3-L1 cells. Carbohydr Res 2011; 346: 1212-1216
    CrossrefPubMedGoogle Scholar
  • 51 Kasturi R, Joshi VC. Hormonal regulation of stearoyl coenzyme A desaturase activity and lipogenesis during adipose conversion 3 T3-L1 cells. J Biol Chem 1982; 257: 12224-12230
    PubMedGoogle Scholar